产品标题 |
产品货号 |
产品规格 |
厂家 |
Papillary renal cell carcinoma (translocation-associated) (PRCC), transcript variant 1 from ORIGENE TECHNOLOGIES | LY416956 | 100 ug | ORIGENE TECHNOLOGIES |
PAPL - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN411792 | 1 kit | ORIGENE TECHNOLOGIES |
Papl - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN512792 | 1 kit | ORIGENE TECHNOLOGIES |
PAPLN - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN415983 | 1 kit | ORIGENE TECHNOLOGIES |
Papln - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN512793 | 1 kit | ORIGENE TECHNOLOGIES |
ENG Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH321699 | 10 ug | ORIGENE TECHNOLOGIES |
ENG Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH326069 | 10 ug | ORIGENE TECHNOLOGIES |
Engrailed homeobox 1 (EN1) from ORIGENE TECHNOLOGIES | LY419942 | 100 ug | ORIGENE TECHNOLOGIES |
Engrailed homeobox 2 (EN2) from ORIGENE TECHNOLOGIES | LY419943 | 100 ug | ORIGENE TECHNOLOGIES |
Engulfment and cell motility 1 (ELMO1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415009 | 100 ug | ORIGENE TECHNOLOGIES |
Engulfment and cell motility 1 (ELMO1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429438 | 100 ug | ORIGENE TECHNOLOGIES |
Engulfment and cell motility 1 (ELMO1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY403326 | 100 ug | ORIGENE TECHNOLOGIES |
Engulfment and cell motility 1 (ELMO1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY422048 | 100 ug | ORIGENE TECHNOLOGIES |
Engulfment and cell motility 2 (ELMO2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY408841 | 100 ug | ORIGENE TECHNOLOGIES |
Engulfment and cell motility 2 (ELMO2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405335 | 100 ug | ORIGENE TECHNOLOGIES |
Human NSFL1 (p97) cofactor (p47) (NSFL1C), transcript variant 1 from ORIGENE TECHNOLOGIES | TP301022 | 20 ug | ORIGENE TECHNOLOGIES |
Human NSL1, MIND kinetochore complex component, homolog (S. cerevisiae) (NSL1), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP760853 | 50 ug | ORIGENE TECHNOLOGIES |
DPF2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN402364 | 1 kit | ORIGENE TECHNOLOGIES |
DPF1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN413721 | 1 kit | ORIGENE TECHNOLOGIES |
DPF3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418937 | 1 kit | ORIGENE TECHNOLOGIES |
Dpf1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504767 | 1 kit | ORIGENE TECHNOLOGIES |
Dpf2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504768 | 1 kit | ORIGENE TECHNOLOGIES |
Dpf3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504769 | 1 kit | ORIGENE TECHNOLOGIES |
DPF1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH325651 | 10 ug | ORIGENE TECHNOLOGIES |
DPF2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH302364 | 10 ug | ORIGENE TECHNOLOGIES |
DPH3B, KTI11 homolog B (S. cerevisiae) (DPH3B) from ORIGENE TECHNOLOGIES | LY429956 | 100 ug | ORIGENE TECHNOLOGIES |
Mouse ANGPTL3 ELISA Kit from ORIGENE TECHNOLOGIES | EA100816 | 8x12 divisible strip | ORIGENE TECHNOLOGIES |
Human immunoglobulin (CD79A) binding protein 1 (IGBP1) from ORIGENE TECHNOLOGIES | TP300387 | 20 ug | ORIGENE TECHNOLOGIES |
Human Cytomegalovirus (CMV) IgG ELISA kit from ORIGENE TECHNOLOGIES | EA100936 | 8x12 divisible strips | ORIGENE TECHNOLOGIES |
Human Cytomegalovirus (CMV) IgG ELISA kit from ORIGENE TECHNOLOGIES | EA101000 | 96-well strip plate | ORIGENE TECHNOLOGIES |
Human Cytomegalovirus (CMV) IgM ELISA kit from ORIGENE TECHNOLOGIES | EA100937 | 8x12 divisible strips | ORIGENE TECHNOLOGIES |
Human Cytomegalovirus (CMV) IgM ELISA kit from ORIGENE TECHNOLOGIES | EA101001 | 96-well strip plate | ORIGENE TECHNOLOGIES |
RAB40A, member RAS oncogene family-like (RAB40AL) from ORIGENE TECHNOLOGIES | LY422201 | 100 ug | ORIGENE TECHNOLOGIES |
RAB11A, member RAS oncogene family (RAB11A) from ORIGENE TECHNOLOGIES | LY401478 | 100 ug | ORIGENE TECHNOLOGIES |
RAB22A, member RAS oncogene family (RAB22A) from ORIGENE TECHNOLOGIES | LY402804 | 100 ug | ORIGENE TECHNOLOGIES |
RAB2A, member RAS oncogene family (RAB2A) from ORIGENE TECHNOLOGIES | LY419058 | 100 ug | ORIGENE TECHNOLOGIES |
RAB33A, member RAS oncogene family (RAB33A) from ORIGENE TECHNOLOGIES | LY417747 | 100 ug | ORIGENE TECHNOLOGIES |
RAB3A, member RAS oncogene family (RAB3A) from ORIGENE TECHNOLOGIES | LY419059 | 100 ug | ORIGENE TECHNOLOGIES |
RAB40A, member RAS oncogene family (RAB40A) from ORIGENE TECHNOLOGIES | LY408996 | 100 ug | ORIGENE TECHNOLOGIES |
RAB4A, member RAS oncogene family (RAB4A) from ORIGENE TECHNOLOGIES | LY401450 | 100 ug | ORIGENE TECHNOLOGIES |
RAB5A, member RAS oncogene family (RAB5A) from ORIGENE TECHNOLOGIES | LY401339 | 100 ug | ORIGENE TECHNOLOGIES |
RAB7A, member RAS oncogene family (RAB7A) from ORIGENE TECHNOLOGIES | LY417854 | 100 ug | ORIGENE TECHNOLOGIES |
RAB8A, member RAS oncogene family (RAB8A) from ORIGENE TECHNOLOGIES | LY417348 | 100 ug | ORIGENE TECHNOLOGIES |
RAB9A, member RAS oncogene family (RAB9A) from ORIGENE TECHNOLOGIES | LY401363 | 100 ug | ORIGENE TECHNOLOGIES |
Human IMP (inosine monophosphate) dehydrogenase 2 (IMPDH2) from ORIGENE TECHNOLOGIES | TP302977 | 20 ug | ORIGENE TECHNOLOGIES |
Human IMP (inosine 5'-monophosphate) dehydrogenase 2 (IMPDH2) from ORIGENE TECHNOLOGIES | TP721014 | 10 ug | ORIGENE TECHNOLOGIES |
Human IMP (inosine monophosphate) dehydrogenase 1 (IMPDH1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP315206 | 20 ug | ORIGENE TECHNOLOGIES |
Human IMP (inosine monophosphate) dehydrogenase 1 (IMPDH1), transcript variant 2 from ORIGENE TECHNOLOGIES | TP307118 | 20 ug | ORIGENE TECHNOLOGIES |
Human importin 4 (IPO4) from ORIGENE TECHNOLOGIES | TP311049 | 20 ug | ORIGENE TECHNOLOGIES |
Human importin 13 (IPO13), full length from ORIGENE TECHNOLOGIES | TP710254 | 20 ug | ORIGENE TECHNOLOGIES |